In patients with T2DM and chronic liver disease attributed to MASLD, the risk of major adverse liver outcomes after GLP-1RA treatment over 10 years fails to decrease (15.8% vs
Dermal fillers restore facial volume while lasers tighten neck and body skin
The HGF/c-Met pathway activated by Dihexa promotes neurite extension, axonal growth, and formation of both pre-synaptic terminals and post-synaptic densities essential for functional neural communication
16 Figure 3: Risk of OACs in patients on GLP-1s versus patients on insulin Conclusion GLP-1s, initially developed to help manage and treat diabetes and later used to treat obesity, are now showing significant potential to help prevent and treat CVD, mental health disorders, liver and kidney disorders, neurodegenerative disorders, addiction disorders, and cancer
Scientists discovered the use of a tanning peptide when investing in possible ways to treat skin cancer
Managing Pernicious Anaemia in the time of Corononavirus Dr